Bank of America
NDRAW

Bank of America’s ENDRA Life Sciences Inc. Warrants NDRAW Stock Holding History

Bank of America’s Portfolio NDRAW Stock Details NDRAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-100
Closed – – 7326
2020
Q2 		$0 Hold
100
– – ﹤0.01% 7278
2020
Q1 		$0 Hold
100
– – ﹤0.01% 7426
2019
Q4 		$0 Buy
+100
New +$36 ﹤0.01% 7567

Bank of America's NDRAW Position: Q3 2020 in Review

Bank of America sold out of ENDRA Life Sciences Inc. Warrants (NDRAW) in Q3 2020, closing a stake of 100 shares.

Bank of America first reported a position in NDRAW in Q4 2019 and held it in 3 quarters. The position peaked at $0 in Q2 2020. 1 fund tracked by Wall St. Rank holds NDRAW as of Q3 2020.

  • Bank of America reported no remaining ENDRA Life Sciences Inc. Warrants position as of Q3 2020 after selling out during the quarter.
  • Bank of America sold 100 ENDRA Life Sciences Inc. Warrants shares in Q3 2020.
  • Bank of America first reported a position in ENDRA Life Sciences Inc. Warrants in Q4 2019 and held it in 3 quarters.
  • Bank of America's ENDRA Life Sciences Inc. Warrants position peaked at $0 in Q2 2020.
  • 1 fund tracked by Wall St. Rank held ENDRA Life Sciences Inc. Warrants as of Q3 2020.

Based on Bank of America's 13F filing for Q3 2020, filed 13 Nov 2020.